Serveur d'exploration autour de Joseph Jankovic

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach

Identifieur interne : 000399 ( Istex/Corpus ); précédent : 000398; suivant : 000400

Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach

Auteurs : Franziska Maier ; Catharine. Lewis ; Nina Horstkoetter ; Carsten Eggers ; Elke Kalbe ; Mohammad Maarouf ; Jens Kuhn ; Mateusz Zurowski ; Elena Moro ; Christiane Woopen ; Lars Timmermann

Source :

RBID : ISTEX:436610088435E9614BE05D633E7A803476F69355

Abstract

Objective To study patients’ expectations of subthalamic deep brain stimulation (STN-DBS) and their subjective perceived outcome, by using qualitative and quantitative methods in Parkinson's disease (PD). Methods PD patients were prospectively examined before and 3 months after surgery. Semistructured interviews regarding preoperative expectations and postsurgical subjective perceived outcome were conducted. These were analysed using content analysis. For statistical analyses, patients were classified according to their subjective perceived outcome, resulting in three different subjective outcome groups (negative, mixed, positive outcome). The groups were used for multiple comparisons between and within each group regarding motor impairment, quality of life (QoL), neuropsychiatric status and cognitive functioning, using standard instruments. A logistic regression analysis was conducted to find predictors of subjective negative outcome. Receiver operating characteristic curves were used to analyse cut-off scores for predictive tests. Results Of the 30 PD patients participating, 8 had a subjective negative outcome, 8 a mixed and 14 a positive outcome. All groups significantly improved in motor functioning. Patients with subjective negative outcome were characterised by preoperative unrealistic expectations, no postsurgical improvement in QoL, and significantly higher presurgical and postsurgical apathy and depression scores. Higher preoperative apathy and depression scores were significant predictors of negative subjective outcome. Cut-off scores for apathy and depression were identified. Conclusions The mixed-method approach proved useful in examining a patient's subjective perception of STN-DBS outcome. Our results show that significant motor improvement does not necessarily lead to a positive subjective outcome. Moreover, PD patients should be screened carefully before surgery regarding apathy and depression. (DRKS-ID: DRKS00003221).

Url:
DOI: 10.1136/jnnp-2012-303670

Links to Exploration step

ISTEX:436610088435E9614BE05D633E7A803476F69355

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</title>
<author>
<name sortKey="Maier, Franziska" sort="Maier, Franziska" uniqKey="Maier F" first="Franziska" last="Maier">Franziska Maier</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lewis, Catharine J" sort="Lewis, Catharine J" uniqKey="Lewis C" first="Catharine" last="Lewis">Catharine. Lewis</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Horstkoetter, Nina" sort="Horstkoetter, Nina" uniqKey="Horstkoetter N" first="Nina" last="Horstkoetter">Nina Horstkoetter</name>
<affiliation>
<mods:affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Eggers, Carsten" sort="Eggers, Carsten" uniqKey="Eggers C" first="Carsten" last="Eggers">Carsten Eggers</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kalbe, Elke" sort="Kalbe, Elke" uniqKey="Kalbe E" first="Elke" last="Kalbe">Elke Kalbe</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Institute for Gerontology, University of Vechta, Vechta, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maarouf, Mohammad" sort="Maarouf, Mohammad" uniqKey="Maarouf M" first="Mohammad" last="Maarouf">Mohammad Maarouf</name>
<affiliation>
<mods:affiliation>Department of Stereotaxy and Functional Neurosurgery, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kuhn, Jens" sort="Kuhn, Jens" uniqKey="Kuhn J" first="Jens" last="Kuhn">Jens Kuhn</name>
<affiliation>
<mods:affiliation>Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name>
<affiliation>
<mods:affiliation>Department of Psychiatry, Department of Medicine, University of Toronto, University Health Network, Toronto, Ontario, Canada</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moro, Elena" sort="Moro, Elena" uniqKey="Moro E" first="Elena" last="Moro">Elena Moro</name>
<affiliation>
<mods:affiliation>Movement Disorders Unit, Department of Psychiatry and Neurology, University Hospital Center (CHU) of Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Woopen, Christiane" sort="Woopen, Christiane" uniqKey="Woopen C" first="Christiane" last="Woopen">Christiane Woopen</name>
<affiliation>
<mods:affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Timmermann, Lars" sort="Timmermann, Lars" uniqKey="Timmermann L" first="Lars" last="Timmermann">Lars Timmermann</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:436610088435E9614BE05D633E7A803476F69355</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1136/jnnp-2012-303670</idno>
<idno type="url">https://api.istex.fr/document/436610088435E9614BE05D633E7A803476F69355/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000399</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</title>
<author>
<name sortKey="Maier, Franziska" sort="Maier, Franziska" uniqKey="Maier F" first="Franziska" last="Maier">Franziska Maier</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lewis, Catharine J" sort="Lewis, Catharine J" uniqKey="Lewis C" first="Catharine" last="Lewis">Catharine. Lewis</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Horstkoetter, Nina" sort="Horstkoetter, Nina" uniqKey="Horstkoetter N" first="Nina" last="Horstkoetter">Nina Horstkoetter</name>
<affiliation>
<mods:affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Eggers, Carsten" sort="Eggers, Carsten" uniqKey="Eggers C" first="Carsten" last="Eggers">Carsten Eggers</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kalbe, Elke" sort="Kalbe, Elke" uniqKey="Kalbe E" first="Elke" last="Kalbe">Elke Kalbe</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Institute for Gerontology, University of Vechta, Vechta, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maarouf, Mohammad" sort="Maarouf, Mohammad" uniqKey="Maarouf M" first="Mohammad" last="Maarouf">Mohammad Maarouf</name>
<affiliation>
<mods:affiliation>Department of Stereotaxy and Functional Neurosurgery, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kuhn, Jens" sort="Kuhn, Jens" uniqKey="Kuhn J" first="Jens" last="Kuhn">Jens Kuhn</name>
<affiliation>
<mods:affiliation>Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name>
<affiliation>
<mods:affiliation>Department of Psychiatry, Department of Medicine, University of Toronto, University Health Network, Toronto, Ontario, Canada</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moro, Elena" sort="Moro, Elena" uniqKey="Moro E" first="Elena" last="Moro">Elena Moro</name>
<affiliation>
<mods:affiliation>Movement Disorders Unit, Department of Psychiatry and Neurology, University Hospital Center (CHU) of Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Woopen, Christiane" sort="Woopen, Christiane" uniqKey="Woopen C" first="Christiane" last="Woopen">Christiane Woopen</name>
<affiliation>
<mods:affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Timmermann, Lars" sort="Timmermann, Lars" uniqKey="Timmermann L" first="Lars" last="Timmermann">Lars Timmermann</name>
<affiliation>
<mods:affiliation>Department of Neurology, University of Cologne, Cologne, Germany</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title>
<title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title>
<idno type="ISSN">0022-3050</idno>
<idno type="eISSN">1468-330X</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd</publisher>
<date type="published" when="2013-11">2013-11</date>
<biblScope unit="volume">84</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1273">1273</biblScope>
</imprint>
<idno type="ISSN">0022-3050</idno>
</series>
<idno type="istex">436610088435E9614BE05D633E7A803476F69355</idno>
<idno type="DOI">10.1136/jnnp-2012-303670</idno>
<idno type="href">jnnp-84-1273.pdf</idno>
<idno type="ArticleID">jnnp-2012-303670</idno>
<idno type="PMID">23715910</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-3050</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Objective To study patients’ expectations of subthalamic deep brain stimulation (STN-DBS) and their subjective perceived outcome, by using qualitative and quantitative methods in Parkinson's disease (PD). Methods PD patients were prospectively examined before and 3 months after surgery. Semistructured interviews regarding preoperative expectations and postsurgical subjective perceived outcome were conducted. These were analysed using content analysis. For statistical analyses, patients were classified according to their subjective perceived outcome, resulting in three different subjective outcome groups (negative, mixed, positive outcome). The groups were used for multiple comparisons between and within each group regarding motor impairment, quality of life (QoL), neuropsychiatric status and cognitive functioning, using standard instruments. A logistic regression analysis was conducted to find predictors of subjective negative outcome. Receiver operating characteristic curves were used to analyse cut-off scores for predictive tests. Results Of the 30 PD patients participating, 8 had a subjective negative outcome, 8 a mixed and 14 a positive outcome. All groups significantly improved in motor functioning. Patients with subjective negative outcome were characterised by preoperative unrealistic expectations, no postsurgical improvement in QoL, and significantly higher presurgical and postsurgical apathy and depression scores. Higher preoperative apathy and depression scores were significant predictors of negative subjective outcome. Cut-off scores for apathy and depression were identified. Conclusions The mixed-method approach proved useful in examining a patient's subjective perception of STN-DBS outcome. Our results show that significant motor improvement does not necessarily lead to a positive subjective outcome. Moreover, PD patients should be screened carefully before surgery regarding apathy and depression. (DRKS-ID: DRKS00003221).</div>
</front>
</TEI>
<istex>
<corpusName>bmj</corpusName>
<author>
<json:item>
<name>Franziska Maier</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Catharine J Lewis</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Nina Horstkoetter</name>
<affiliations>
<json:string>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Carsten Eggers</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Elke Kalbe</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
<json:string>Institute for Gerontology, University of Vechta, Vechta, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Mohammad Maarouf</name>
<affiliations>
<json:string>Department of Stereotaxy and Functional Neurosurgery, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Jens Kuhn</name>
<affiliations>
<json:string>Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Mateusz Zurowski</name>
<affiliations>
<json:string>Department of Psychiatry, Department of Medicine, University of Toronto, University Health Network, Toronto, Ontario, Canada</json:string>
</affiliations>
</json:item>
<json:item>
<name>Elena Moro</name>
<affiliations>
<json:string>Movement Disorders Unit, Department of Psychiatry and Neurology, University Hospital Center (CHU) of Grenoble, Grenoble, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Christiane Woopen</name>
<affiliations>
<json:string>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Lars Timmermann</name>
<affiliations>
<json:string>Department of Neurology, University of Cologne, Cologne, Germany</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Movement disorders</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>JNNP Patients' choice</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PARKINSON'S DISEASE</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NEUROPSYCHIATRY</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>NEUROPSYCHOLOGY</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>QUALITY OF LIFE</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>STEREOTAXIC SURGERY</value>
</json:item>
</subject>
<language>
<json:string>eng</json:string>
</language>
<abstract>Objective To study patients’ expectations of subthalamic deep brain stimulation (STN-DBS) and their subjective perceived outcome, by using qualitative and quantitative methods in Parkinson's disease (PD). Methods PD patients were prospectively examined before and 3 months after surgery. Semistructured interviews regarding preoperative expectations and postsurgical subjective perceived outcome were conducted. These were analysed using content analysis. For statistical analyses, patients were classified according to their subjective perceived outcome, resulting in three different subjective outcome groups (negative, mixed, positive outcome). The groups were used for multiple comparisons between and within each group regarding motor impairment, quality of life (QoL), neuropsychiatric status and cognitive functioning, using standard instruments. A logistic regression analysis was conducted to find predictors of subjective negative outcome. Receiver operating characteristic curves were used to analyse cut-off scores for predictive tests. Results Of the 30 PD patients participating, 8 had a subjective negative outcome, 8 a mixed and 14 a positive outcome. All groups significantly improved in motor functioning. Patients with subjective negative outcome were characterised by preoperative unrealistic expectations, no postsurgical improvement in QoL, and significantly higher presurgical and postsurgical apathy and depression scores. Higher preoperative apathy and depression scores were significant predictors of negative subjective outcome. Cut-off scores for apathy and depression were identified. Conclusions The mixed-method approach proved useful in examining a patient's subjective perception of STN-DBS outcome. Our results show that significant motor improvement does not necessarily lead to a positive subjective outcome. Moreover, PD patients should be screened carefully before surgery regarding apathy and depression. (DRKS-ID: DRKS00003221).</abstract>
<qualityIndicators>
<score>8</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>595.276 x 793.701 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>7</keywordCount>
<abstractCharCount>1968</abstractCharCount>
<pdfWordCount>5545</pdfWordCount>
<pdfCharCount>39719</pdfCharCount>
<pdfPageCount>9</pdfPageCount>
<abstractWordCount>252</abstractWordCount>
</qualityIndicators>
<title>Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</title>
<pmid>
<json:string>23715910</json:string>
</pmid>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<volume>84</volume>
<pages>
<first>1273</first>
</pages>
<issn>
<json:string>0022-3050</json:string>
</issn>
<issue>11</issue>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1468-330X</json:string>
</eissn>
<title>Journal of Neurology, Neurosurgery & Psychiatry</title>
</host>
<publicationDate>2013</publicationDate>
<copyrightDate>2013</copyrightDate>
<doi>
<json:string>10.1136/jnnp-2012-303670</json:string>
</doi>
<id>436610088435E9614BE05D633E7A803476F69355</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/436610088435E9614BE05D633E7A803476F69355/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/436610088435E9614BE05D633E7A803476F69355/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/436610088435E9614BE05D633E7A803476F69355/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a">Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>BMJ Publishing Group Ltd</publisher>
<availability>
<p>BMJ</p>
</availability>
<date>2013-05-28</date>
</publicationStmt>
<notesStmt>
<note>FM and CJL contributed equally.</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a">Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</title>
<author>
<persName>
<forename type="first">Franziska</forename>
<surname>Maier</surname>
</persName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Catharine J</forename>
<surname>Lewis</surname>
</persName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Nina</forename>
<surname>Horstkoetter</surname>
</persName>
<affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Carsten</forename>
<surname>Eggers</surname>
</persName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Elke</forename>
<surname>Kalbe</surname>
</persName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Institute for Gerontology, University of Vechta, Vechta, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Mohammad</forename>
<surname>Maarouf</surname>
</persName>
<affiliation>Department of Stereotaxy and Functional Neurosurgery, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Jens</forename>
<surname>Kuhn</surname>
</persName>
<affiliation>Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Mateusz</forename>
<surname>Zurowski</surname>
</persName>
<affiliation>Department of Psychiatry, Department of Medicine, University of Toronto, University Health Network, Toronto, Ontario, Canada</affiliation>
</author>
<author>
<persName>
<forename type="first">Elena</forename>
<surname>Moro</surname>
</persName>
<affiliation>Movement Disorders Unit, Department of Psychiatry and Neurology, University Hospital Center (CHU) of Grenoble, Grenoble, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Christiane</forename>
<surname>Woopen</surname>
</persName>
<affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">Lars</forename>
<surname>Timmermann</surname>
</persName>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title>
<title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title>
<idno type="JournalID">jnnp</idno>
<idno type="pISSN">0022-3050</idno>
<idno type="eISSN">1468-330X</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd</publisher>
<date type="published" when="2013-11"></date>
<biblScope unit="volume">84</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1273">1273</biblScope>
</imprint>
</monogr>
<idno type="istex">436610088435E9614BE05D633E7A803476F69355</idno>
<idno type="DOI">10.1136/jnnp-2012-303670</idno>
<idno type="href">jnnp-84-1273.pdf</idno>
<idno type="ArticleID">jnnp-2012-303670</idno>
<idno type="PMID">23715910</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2013-05-28</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract>
<p>Objective To study patients’ expectations of subthalamic deep brain stimulation (STN-DBS) and their subjective perceived outcome, by using qualitative and quantitative methods in Parkinson's disease (PD). Methods PD patients were prospectively examined before and 3 months after surgery. Semistructured interviews regarding preoperative expectations and postsurgical subjective perceived outcome were conducted. These were analysed using content analysis. For statistical analyses, patients were classified according to their subjective perceived outcome, resulting in three different subjective outcome groups (negative, mixed, positive outcome). The groups were used for multiple comparisons between and within each group regarding motor impairment, quality of life (QoL), neuropsychiatric status and cognitive functioning, using standard instruments. A logistic regression analysis was conducted to find predictors of subjective negative outcome. Receiver operating characteristic curves were used to analyse cut-off scores for predictive tests. Results Of the 30 PD patients participating, 8 had a subjective negative outcome, 8 a mixed and 14 a positive outcome. All groups significantly improved in motor functioning. Patients with subjective negative outcome were characterised by preoperative unrealistic expectations, no postsurgical improvement in QoL, and significantly higher presurgical and postsurgical apathy and depression scores. Higher preoperative apathy and depression scores were significant predictors of negative subjective outcome. Cut-off scores for apathy and depression were identified. Conclusions The mixed-method approach proved useful in examining a patient's subjective perception of STN-DBS outcome. Our results show that significant motor improvement does not necessarily lead to a positive subjective outcome. Moreover, PD patients should be screened carefully before surgery regarding apathy and depression. (DRKS-ID: DRKS00003221).</p>
</abstract>
<textClass>
<keywords scheme="keyword">
<list>
<head>heading</head>
<item>
<term>Movement disorders</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="keyword">
<list>
<head>heading</head>
<item>
<term>JNNP Patients' choice</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>PARKINSON'S DISEASE</term>
</item>
<item>
<term>NEUROPSYCHIATRY</term>
</item>
<item>
<term>NEUROPSYCHOLOGY</term>
</item>
<item>
<term>QUALITY OF LIFE</term>
</item>
<item>
<term>STEREOTAXIC SURGERY</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2013-05-28">Created</change>
<change when="2013-11">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/436610088435E9614BE05D633E7A803476F69355/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus not found" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType>
<istex:document>
<article article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">jnnp</journal-id>
<journal-id journal-id-type="nlm-ta">J Neurol Neurosurg Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">jnnp</journal-id>
<journal-title>Journal of Neurology, Neurosurgery & Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="publisher">J Neurol Neurosurg Psychiatry</abbrev-journal-title>
<abbrev-journal-title>J Neurol Neurosurg Psychiatry</abbrev-journal-title>
<issn pub-type="ppub">0022-3050</issn>
<issn pub-type="epub">1468-330X</issn>
<publisher>
<publisher-name>BMJ Publishing Group Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">jnnp-2012-303670</article-id>
<article-id pub-id-type="doi">10.1136/jnnp-2012-303670</article-id>
<article-id pub-id-type="other">jnnp;84/11/1273</article-id>
<article-id pub-id-type="other">jnnp;jnnp-2012-303670</article-id>
<article-id pub-id-type="pmid">23715910</article-id>
<article-id pub-id-type="other">1273</article-id>
<article-id pub-id-type="other">jnnp-2012-303670</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Movement disorders</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>JNNP Patients' choice</subject>
</subj-group>
<series-title>Research paper</series-title>
</article-categories>
<title-group>
<article-title>Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Maier</surname>
<given-names>Franziska</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Catharine J</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horstkoetter</surname>
<given-names>Nina</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eggers</surname>
<given-names>Carsten</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalbe</surname>
<given-names>Elke</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maarouf</surname>
<given-names>Mohammad</given-names>
</name>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuhn</surname>
<given-names>Jens</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zurowski</surname>
<given-names>Mateusz</given-names>
</name>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moro</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="af7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Woopen</surname>
<given-names>Christiane</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Timmermann</surname>
<given-names>Lars</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
</contrib-group>
<aff id="af1">
<label>1</label>
<addr-line>Department of Neurology</addr-line>
,
<institution>University of Cologne</institution>
,
<addr-line>Cologne</addr-line>
,
<country>Germany</country>
</aff>
<aff id="af2">
<label>2</label>
<addr-line>Research Unit Ethics</addr-line>
,
<institution>Institute for the History of Medicine and Medical Ethics, University of Cologne</institution>
,
<addr-line>Cologne</addr-line>
,
<country>Germany</country>
</aff>
<aff id="af3">
<label>3</label>
<institution>Institute for Gerontology, University of Vechta</institution>
,
<addr-line>Vechta</addr-line>
,
<country>Germany</country>
</aff>
<aff id="af4">
<label>4</label>
<addr-line>Department of Stereotaxy and Functional Neurosurgery</addr-line>
,
<institution>University of Cologne</institution>
,
<addr-line>Cologne</addr-line>
,
<country>Germany</country>
</aff>
<aff id="af5">
<label>5</label>
<addr-line>Department of Psychiatry and Psychotherapy</addr-line>
,
<institution>University of Cologne</institution>
,
<addr-line>Cologne</addr-line>
,
<country>Germany</country>
</aff>
<aff id="af6">
<label>6</label>
<addr-line>Department of Psychiatry, Department of Medicine</addr-line>
,
<institution>University of Toronto, University Health Network</institution>
,
<addr-line>Toronto, Ontario</addr-line>
,
<country>Canada</country>
</aff>
<aff id="af7">
<label>7</label>
<addr-line>Movement Disorders Unit, Department of Psychiatry and Neurology</addr-line>
,
<institution>University Hospital Center (CHU) of Grenoble</institution>
,
<addr-line>Grenoble</addr-line>
,
<country>France</country>
</aff>
<author-notes>
<corresp>
<label>Correspondence to</label>
Franziska Maier, Department of Neurology, University Hospital Cologne, Kerpener Str. 62, Cologne D-50937, Germany;
<email>franziska.maier@uk-koeln.de</email>
</corresp>
<fn>
<p>FM and CJL contributed equally.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub-original">
<day>28</day>
<month>5</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>5</month>
<year>2013</year>
</pub-date>
<volume>84</volume>
<volume-id pub-id-type="other">84</volume-id>
<volume-id pub-id-type="other">84</volume-id>
<issue>11</issue>
<issue-id pub-id-type="other">jnnp;84/11</issue-id>
<issue-id pub-id-type="other">11</issue-id>
<issue-id pub-id-type="other">84/11</issue-id>
<fpage>1273</fpage>
<history>
<date date-type="received">
<day>13</day>
<month>7</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>2</day>
<month>4</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>5</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</copyright-statement>
<copyright-year>2013</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:role="full-text" xlink:href="jnnp-84-1273.pdf"></self-uri>
<abstract>
<sec>
<title>Objective</title>
<p>To study patients’ expectations of subthalamic deep brain stimulation (STN-DBS) and their subjective perceived outcome, by using qualitative and quantitative methods in Parkinson's disease (PD).</p>
</sec>
<sec>
<title>Methods</title>
<p>PD patients were prospectively examined before and 3 months after surgery. Semistructured interviews regarding preoperative expectations and postsurgical subjective perceived outcome were conducted. These were analysed using content analysis. For statistical analyses, patients were classified according to their subjective perceived outcome, resulting in three different subjective outcome groups (negative, mixed, positive outcome). The groups were used for multiple comparisons between and within each group regarding motor impairment, quality of life (QoL), neuropsychiatric status and cognitive functioning, using standard instruments. A logistic regression analysis was conducted to find predictors of subjective negative outcome. Receiver operating characteristic curves were used to analyse cut-off scores for predictive tests.</p>
</sec>
<sec>
<title>Results</title>
<p>Of the 30 PD patients participating, 8 had a subjective negative outcome, 8 a mixed and 14 a positive outcome. All groups significantly improved in motor functioning. Patients with subjective negative outcome were characterised by preoperative unrealistic expectations, no postsurgical improvement in QoL, and significantly higher presurgical and postsurgical apathy and depression scores. Higher preoperative apathy and depression scores were significant predictors of negative subjective outcome. Cut-off scores for apathy and depression were identified.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>The mixed-method approach proved useful in examining a patient's subjective perception of STN-DBS outcome. Our results show that significant motor improvement does not necessarily lead to a positive subjective outcome. Moreover, PD patients should be screened carefully before surgery regarding apathy and depression. (DRKS-ID: DRKS00003221).</p>
</sec>
</abstract>
<kwd-group>
<kwd>PARKINSON'S DISEASE</kwd>
<kwd>NEUROPSYCHIATRY</kwd>
<kwd>NEUROPSYCHOLOGY</kwd>
<kwd>QUALITY OF LIFE</kwd>
<kwd>STEREOTAXIC SURGERY</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Parkinson's disease (PD) is a neurodegenerative disorder characterised by a variety of typical motor and non-motor impairments. While bilateral subthalamic deep brain stimulation (STN-DBS) significantly improves the motor difficulties,
<xref ref-type="bibr" rid="R1">1</xref>
there is an ongoing discussion on how STN-DBS influences behavioural and cognitive symptoms.
<xref ref-type="bibr" rid="R2">2</xref>
<xref ref-type="bibr" rid="R3">3</xref>
PD-specific quality of life (QoL), measured with the Parkinson's Disease Questionnaire-39 (PDQ-39),
<xref ref-type="bibr" rid="R4">4</xref>
is an often used outcome parameter for STN-DBS. By using this scale, a significant improvement of QoL under STN-DBS has been demonstrated.
<xref ref-type="bibr" rid="R1">1</xref>
<xref ref-type="bibr" rid="R5">5</xref>
This finding stands in contrast with reports on patients who perceive their outcome as disappointing, even though they had experienced significant motor benefits and improvement in QoL.
<xref ref-type="bibr" rid="R6">6</xref>
More in-depth examinations of QoL following STN-DBS have revealed a predominant improvement of physical domains, while mental subscales remain stable or even worsen.
<xref ref-type="bibr" rid="R7">7</xref>
The clinical need of identifying patients who are at higher risk of perceiving their postoperative outcome as unsatisfactory has attracted more attention lately.
<xref ref-type="bibr" rid="R6">6</xref>
<xref ref-type="bibr" rid="R8">8</xref>
<xref ref-type="bibr" rid="R9">9</xref>
By focussing on the patient, individual realistic and unrealistic expectations can be considered. To gain information about this, the combination of qualitative patient interviews with standard measures for a better understanding of subjective outcome might be a successful approach.
<xref ref-type="bibr" rid="R10">10</xref>
<xref ref-type="bibr" rid="R11">11</xref>
Concerning research on STN-DBS in PD patients, only a few studies used well-appreciated standard instruments (eg, the PDQ-39), as well as supplementary semistructured or open in-depth interviews to explore patient's subjective perception of DBS therapy.
<xref ref-type="bibr" rid="R6">6</xref>
<xref ref-type="bibr" rid="R12">12</xref>
</p>
<p>Predictors or influencing factors of psychosocial outcome and improved QoL after STN-DBS have been tried to be identified by using standard scales
<xref ref-type="bibr" rid="R13 R14 R15 R16">13–16</xref>
or modified standard scales.
<xref ref-type="bibr" rid="R9">9</xref>
Postsurgical improved QoL has been linked to preoperative cumulative daily off time,
<xref ref-type="bibr" rid="R13">13</xref>
high l-dopa response,
<xref ref-type="bibr" rid="R14">14</xref>
changes in depression and anxiety,
<xref ref-type="bibr" rid="R13">13</xref>
and better cognitive functioning.
<xref ref-type="bibr" rid="R16">16</xref>
Furthermore, neuropsychiatric symptoms, such as depression and apathy, have a major impact on QoL in PD.
<xref ref-type="bibr" rid="R17">17</xref>
<xref ref-type="bibr" rid="R18">18</xref>
</p>
<p>In this study, we used a mixed-method approach of qualitative and quantitative methods to examine the patient's expectations of STN-DBS and perceived outcome at 3 months after surgery. As primary goal, we intended to analyse the number of patients who perceived their subjective outcome as negative, mixed, or positive. Secondarily, we sought to characterise differences between these patients by using standard clinical measures. Finally, we aimed to examine the predictive value of preoperative scores for patients with subjective negative outcome.</p>
</sec>
<sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Patients</title>
<p>We prospectively examined patients with idiopathic PD, recruited from the Department of Neurology, University Hospital Cologne, before surgery (baseline) and 3 months after STN-DBS (3 mFU). All patients met the criteria for STN-DBS treatment according to the guidelines of the German Neurological Society.
<xref ref-type="bibr" rid="R19">19</xref>
Included were patients between 40 and 75 years of age who had medication refractory motor symptoms despite an unequivocal response to l-dopa in the off-state.</p>
<p>Patients with dementia (DemTect-score <9
<xref ref-type="bibr" rid="R20">20</xref>
and MMSE-score <25
<xref ref-type="bibr" rid="R21">21</xref>
), severe psychiatric or additional neurological disorders were excluded. The study was approved by the ethics commission of the University Hospital of Cologne, and all patients gave written informed consent. Furthermore, the study was registered at the German Clinical Trials Register (DRKS-ID: DRKS00003221).</p>
</sec>
<sec id="s2b">
<title>Procedure</title>
<p>As part of the preoperative DBS screening routine in Cologne, all patients were examined by a movement disorder neurologist, a neurosurgeon, a psychiatrist and a neuropsychologist. These experts mutually approved DBS surgery for all patients. For the purpose of this study, patients were additionally interviewed, examined and cognitively tested 6 weeks to 3 days prior to surgery, and 3 months after implantation of the electrodes, by two trained clinical neuropsychologists (F.M. & C.L.).</p>
</sec>
<sec id="s2c">
<title>DBS surgery</title>
<p>All patients underwent STN-DBS surgery at the department for Stereotaxy and Functional Neurosurgery, University Hospital Cologne. Preoperative stereotactic CTs and 1.5T MRIs determined the coordinates of the target structure. Electrodes (standard model 3389; Medtronic, Minneapolis, Minnesota, USA) were implanted bilaterally in the STN under local anaesthesia. Microelectrode recordings and macroelectrode test stimulation determined the optimal implantation area in all patients. To monitor the final location of the electrodes, intraoperative and postoperative stereotactic x-rays were projected on the preoperative stereotactic MRI scans. The electrodes were connected to a pulse generator (Kinetra or Activa RC/PC; Medtronic, Minneapolis, Minnesota, USA) and implanted in the subclavicular area under general anaesthesia. Postoperatively, patients were hospitalised for up to 10 days, according to the standards of care of our centre. STN-stimulation was turned on 3–5 days after surgery on very low amplitudes (0.3–0.5 V, 60 μs, 130 Hz), allowing for immediate microlesion effects to wear off. The main microlesion effect decreased around day 6–10 after surgery. Stimulation amplitude was slowly increased accompanied by a stepwise reduction of antiparkinsonian medication.</p>
</sec>
<sec id="s2d">
<title>Semistructured interviews</title>
<p>In addition to the quantitative data collection, we intended to gain knowledge about the patient's subjective perspective on their disease and DBS. We developed an interview guideline including various different domains that may have an impact on a patient's life with PD and DBS. Preoperatively, the interview focus was set on the following topics: subjective expectations from DBS, presurgical motor, emotional, social, behavioural and cognitive functioning, activities of daily living and QoL. At 3 mFU, the interview contained questions about the impact of DBS on the same domains. The interviews were pretested with five patients to prove understanding and mental resilience. All 60 interviews (30 baseline and 30 3 mFU) were recorded, transcribed and categorised by two independent trained coders (N.H. & C.L.). Categorisation was conducted according to Mayring's theory-based content analysis,
<xref ref-type="bibr" rid="R22">22</xref>
<xref ref-type="bibr" rid="R23">23</xref>
which is a widely used method in health research. For the purpose of this study, categories were analysed with respect to the patient's expectations from DBS before surgery, and the patient's perception of their personal outcome at 3 mFU. At baseline, all expectations that were stated by each patient throughout the interview were collected. At 3 mFU, all statements regarding the impact of DBS on the patient's life, such as improved or worsened symptoms or unexpected changes, were collected for each patient. Thereafter, the number of positive and negative statements related to DBS at 3 mFU was separately summed up, and a quotient was calculated by dividing the number of positive statements by the number of negative statements for each patient (eg, 12 positive divided by 3 negative statements is 4). Neutral responses, such as ‘no change’ answers, were not considered. Finally, patients were grouped according to their subjective outcome quotient: group 1 included patients with a quotient of ≤0.5, representing patients who had at least twice as many negative statements than positive statements. Therefore, the first group contained patients who perceived their subjective outcome as mainly negative (group-neg). The second group included patients with a quotient between >0.5 and <2.0, representing patients who considered their outcome as mixed positive and negative (group-mix). The third group contained patients with a quotient of ≥2, representing patients who had at least twice as many positive statements than negative statements and, thus, perceived their subjective outcome as mainly positive (group-pos).</p>
</sec>
<sec id="s2e">
<title>Clinical rating scales</title>
<p>Motor performance was evaluated using the Unified Parkinson's Disease Rating Scale part III (UPDRS-III)
<xref ref-type="bibr" rid="R24">24</xref>
while on and off l-dopa. Off-state was defined as motor impairment following at least 12 h absence of antiparkinsonian medication, while on-state was the patient's best motor response to first l-dopa dose (at least 200 mg or 1.5 times the individual morning dose) after the off-state. Long-acting dopamine agonists were stopped 72 h prior to off-examination. Also, the l-dopa equivalent daily dose (LEDD)
<xref ref-type="bibr" rid="R25">25</xref>
was determined. At 3 mFU, patients were tested on the UPDRS-III with stimulation on and medication off.</p>
<p>Regarding neuropsychological testing, all patients were examined on the digit span forwards and backwards of the Wechsler memory scale,
<xref ref-type="bibr" rid="R26">26</xref>
phonemic verbal fluency task (letter B, M, S),
<xref ref-type="bibr" rid="R27">27</xref>
and the brief test of attention (BTA).
<xref ref-type="bibr" rid="R28">28</xref>
</p>
<p>To determine patient's QoL, the Parkinson's disease questionnaire-39 (PDQ-39)
<xref ref-type="bibr" rid="R4">4</xref>
was given to all patients at baseline (PDQ-base) and at 3 mFU (PDQ-3 mFU).</p>
<p>With respect to mood examination, the following tests were conducted: apathy evaluation scale (AES, range: 18–72),
<xref ref-type="bibr" rid="R29">29</xref>
Beck depression inventory-2 (BDI-2, range: 0–63),
<xref ref-type="bibr" rid="R30">30</xref>
self-report manic inventory (SRMI, range: 0–48),
<xref ref-type="bibr" rid="R31">31</xref>
and the state subscale of the State trait anxiety inventory (STAI-state, range: 20–80).
<xref ref-type="bibr" rid="R32">32</xref>
For all four scales, higher scores represent more severe symptoms.</p>
</sec>
<sec id="s2f">
<title>Monitoring</title>
<p>All data was transferred into a SPSS database and independently controlled by the PI. To ensure data quality, the Cologne Centre for Clinical Studies (ZKS Cologne), an independent clinical research organisation, monitored 20% of the data. The data quality was rated as very high by the ZKS Cologne.</p>
</sec>
<sec id="s2g">
<title>Statistical analysis</title>
<p>All statistical analyses were conducted using IBM SPSS V.20.0 (SPSS, Chicago, Illinois, USA). Level of significance was set at 0.05. To ensure standard treatment outcome, the whole sample was compared regarding baseline and 3 mFU UPDRS-III-scores and PDQ-scores using paired samples t tests (assumptions for parametric distribution were fulfilled).</p>
<p>All patients were classified according to their individual outcome quotient into three subjective outcome groups (group-neg/-mix/-pos).</p>
<sec id="s2g1">
<title>Group differences</title>
<p>First, the three groups were compared concerning presurgical expectations, and postoperative positive and negative statements using the χ
<sup>2</sup>
test or the Fisher's exact test when one value was not available. Thereafter, for clinical tests, differences between the subjective outcome groups were analysed separately at baseline and at 3 mFU with one-way ANOVAs for parametric variables and with the Kruskall–Wallis H test for nonparametric variables. Significant p values were α-corrected by dividing 0.05 by the number of tests for each analysis. Posthoc Bonferroni test was used to further specify significant group differences. To compare baseline and 3 mFU data within each group, paired samples t tests were computed. Neurological data, neuropsychological measurements, QoL, and mood scales were analysed separately.</p>
</sec>
<sec id="s2g2">
<title>Predictors of subjective negative outcome</title>
<p>A binary logistic regression model was used (forward; LR method), to analyse predictors for group-neg. For this analysis, we only included test scores which showed significant group differences between group-neg and group-mix or/and group-pos at baseline. Because we mainly focussed on patients of group-neg, the dichotomised dependent variable comprised group-neg versus a cluster of group-mix and group-pos.</p>
<p>Exploratively, to determine possible clinically relevant cut-off scores for significant predictors, receiver operating characteristic (ROC) curves were conducted and the area under the curve (AUC) was calculated. Also, sensitivity and specificity were examined for each cut-off score.</p>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3a">
<title>Sample</title>
<p>Thirty patients with PD were enrolled in this study. Mean age of all patients (18 men/12 women) was 61.20±8.65 with an average disease duration of 11.97±6.79 years. Standard treatment outcome was classified as good, as patient's baseline UPDRS-III off-score (42.48±13.07) significantly improved under stimulation at 3 mFU (UPDRS-III stimulation on and medication off: 26.76±13.86; p<0.001, paired samples t test). Similarly, the PDQ-base improved from 37.01±16.54 for all patients to PDQ-3 mFU 26.47±14.94 (p<0.001, paired samples t test).</p>
<p>According to the subjective outcome quotient, 8 patients (26.67%) were assigned to group-neg, 8 patients (26.67%) were classified as group-mix, and 14 patients (46.66%) were assigned to group-pos (see
<xref ref-type="table" rid="JNNP2012303670TB1">table 1</xref>
). Regarding the three subjective outcome groups, no significant differences were found for demographic data and global cognitive state.</p>
<table-wrap id="JNNP2012303670TB1" position="float">
<label>Table 1</label>
<caption>
<p>Group classification, demographic data, and global cognitive functioning of the three outcome groups</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"></col>
<col align="left"></col>
<col align="left"></col>
<col align="left"></col>
<col align="char" char="."></col>
<col align="char" char="."></col>
</colgroup>
<thead valign="bottom">
<tr>
<th></th>
<th align="left">Group-neg</th>
<th align="left">Group-mix</th>
<th align="left">Group-pos</th>
<th align="left">F/χ
<sup>2</sup>
</th>
<th align="left">p Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>N (%)</td>
<td>8 (26.67)</td>
<td>8 (26.67)</td>
<td>14 (46.66)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Number of positive statements</td>
<td>1.88±1.25</td>
<td>5.75±1.67</td>
<td>8.71±1.86</td>
<td>42.971
<sup>a</sup>
</td>
<td><0.001</td>
</tr>
<tr>
<td>Number of negative statements</td>
<td>7.25±1.91</td>
<td>5.13±2.23</td>
<td>1.29±1.49</td>
<td>29.875
<sup>a</sup>
</td>
<td><0.001</td>
</tr>
<tr>
<td>Subjective outcome quotient</td>
<td>0.26±0.14</td>
<td>1.23±0.37</td>
<td>6.45±3.48</td>
<td>21.009
<sup>a</sup>
</td>
<td><0.001</td>
</tr>
<tr>
<td>Age (yr)</td>
<td>60.50±7.19</td>
<td>58.88±9.33</td>
<td>62.93±9.24</td>
<td>0.577
<sup>a</sup>
</td>
<td>0.568</td>
</tr>
<tr>
<td>Sex (m/f)</td>
<td>5/3</td>
<td>3/5</td>
<td>10/4</td>
<td>2.470
<sup>b</sup>
</td>
<td>0.291</td>
</tr>
<tr>
<td>Education (yr)</td>
<td>11.75±4.71</td>
<td>11.38±4.44</td>
<td>11.29±4.20</td>
<td>0.006
<sup>b</sup>
</td>
<td>0.997</td>
</tr>
<tr>
<td>Disease duration (yr)</td>
<td>11.00±4.78</td>
<td>14.38±8.14</td>
<td>11.14±7.07</td>
<td>0.672
<sup>a</sup>
</td>
<td>0.519</td>
</tr>
<tr>
<td>Mini mental state exam</td>
<td>28.88±0.64</td>
<td>29.50±1.07</td>
<td>28.36±1.98</td>
<td>3.178
<sup>b</sup>
</td>
<td>0.204</td>
</tr>
<tr>
<td>DemTect</td>
<td>13.38±2.92</td>
<td>14.75±3.65</td>
<td>15.57±2.41</td>
<td>1.449
<sup>a</sup>
</td>
<td>0.252</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are means (±SD) unless stated otherwise. p Values by
<sup>a</sup>
ANOVA (F) or
<sup>b</sup>
Kruskall–Wallis H-test (
<bold>χ
<sup>2</sup>
</bold>
).</p>
</fn>
<fn>
<p>N, number of patients; group-neg, subjective outcome negative; group-mix, subjective outcome mixed; group-pos, subjective outcome positive.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3b">
<title>Expectations from DBS and subjective outcome reports</title>
<p>All patients expected an improvement of motor symptoms (see
<xref ref-type="fig" rid="JNNP2012303670F1">figure 1</xref>
) while all other expectations varied between the subjective outcome groups. Group-neg patients significantly more often expected ‘improvement of mental state’ compared with the other two groups (p=0.028). Moreover, although not significant, group-neg more often expected ‘more socialising’ or ‘improvement of partnership’, which can usually not be directly improved by STN-DBS (for details see online supplementary). With respect to patient's subjective outcome at 3 mFU (see
<xref ref-type="fig" rid="JNNP2012303670F2">figures 2</xref>
and
<xref ref-type="fig" rid="JNNP2012303670F3">3</xref>
), all patients of group-mix and group-pos experienced ‘improved motor symptoms’ which was significantly more often compared with group-neg (p=0.010). Also, all patients of group-pos, and 87.5% of group-mix named QoL as being improved, which was significantly more often compared with group-neg (p<0.001). Regarding negative statements, group-neg significantly more often reported a worse mental state than the other two groups (p=0.002) (see online supplementary data).</p>
<fig id="JNNP2012303670F1">
<label>Figure 1</label>
<caption>
<p>Patient's expectations concerning STN-DBS for the three groups. All patients were asked to name their expectations regarding STN-DBS in a semistructured interview. Expectations were sorted according to their frequency of being stated by all patients and then classified concerning the three subjective outcome groups. Included were only such statements which were named by >25% of patients within one of the three groups. * Significant difference between the subjective negative outcome group and the other two groups.</p>
</caption>
<graphic xlink:href="jnnp-84-1273-F1.jpg"></graphic>
</fig>
<fig id="JNNP2012303670F2">
<label>Figure 2</label>
<caption>
<p>Positive statements at 3 months after STN-DBS for the three groups. All patients were asked to reflect their subjective outcome regarding STN-DBS in a semistructured interview. Positive statements were sorted according to their frequency of being stated by all patients, and were then classified concerning the three subjective outcome groups. Included were only such statements which were named by >25% of patients within one of the three groups. *Significant difference between the subjective negative outcome group and the other two groups.</p>
</caption>
<graphic xlink:href="jnnp-84-1273-F2.jpg"></graphic>
</fig>
<fig id="JNNP2012303670F3">
<label>Figure 3</label>
<caption>
<p>Negative statements at 3 months after STN-DBS for the three groups. All patients were asked to reflect their subjective outcome regarding STN-DBS in a semistructured interview. Negative statements were sorted according to their frequency of being stated by all patients and were then classified concerning the three subjective outcome groups. Included were only such statements which were named by >25% of patients within one of the three groups. *Significant difference between the subjective negative outcome group and the other two groups.</p>
</caption>
<graphic xlink:href="jnnp-84-1273-F3.jpg"></graphic>
</fig>
</sec>
<sec id="s3c">
<title>Subjective outcome group differences at baseline and 3 mFU</title>
<p>Results of the outcome group differences are depicted in
<xref ref-type="table" rid="JNNP2012303670TB2">tables 2</xref>
and
<xref ref-type="table" rid="JNNP2012303670TB3">3</xref>
.</p>
<table-wrap id="JNNP2012303670TB2" position="float">
<label>Table 2</label>
<caption>
<p>Neurological and neuropsychological data, and quality of life for the three groups at baseline and 3 mFU</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"></col>
<col align="left"></col>
<col align="left"></col>
<col align="char" char="."></col>
<col align="char" char="."></col>
<col align="char" char="."></col>
<col align="left"></col>
<col align="left"></col>
</colgroup>
<thead valign="bottom">
<tr>
<th></th>
<th></th>
<th></th>
<th align="left">Group-neg (n=8)</th>
<th align="left">Group-mix (n=8)</th>
<th align="left">Group-pos (n=14)</th>
<th align="left">F/χ
<sup>2</sup>
</th>
<th align="left">p Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurological data</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>UPDRS-III</td>
<td>Med on</td>
<td>Baseline</td>
<td>16.00±4.14</td>
<td>20.88±7.36</td>
<td>23.57±12.75</td>
<td>2.333
<sup>b</sup>
</td>
<td>0.312</td>
</tr>
<tr>
<td>UPDRS-III</td>
<td>Med off</td>
<td>Baseline</td>
<td>39.88±7.97</td>
<td>40.00±11.89</td>
<td>46.79±16.09</td>
<td>0.985
<sup>a</sup>
</td>
<td>0.386</td>
</tr>
<tr>
<td></td>
<td>Stim on and med off</td>
<td>3 mFU</td>
<td>28.63±10.47**</td>
<td>28.13±9.13*</td>
<td>24.77±18.11***§</td>
<td>0.232
<sup>a</sup>
</td>
<td>0.795</td>
</tr>
<tr>
<td>LEDD (mg)</td>
<td></td>
<td>Baseline</td>
<td>900.75±576.63</td>
<td>806.25±371.63</td>
<td>709.86±340.60</td>
<td>0.534
<sup>a</sup>
</td>
<td>0.593</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3 mFU</td>
<td>479.58±299.94*</td>
<td>250.42±243.01**</td>
<td>326.36±116.41**</td>
<td>2.000
<sup>b</sup>
</td>
<td>0.368</td>
</tr>
<tr>
<td>Neuropsychological data</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Digit span forwards T-scores</td>
<td></td>
<td>Baseline</td>
<td>58.13±9.46</td>
<td>57.86±9.25§</td>
<td>53.86±11.26</td>
<td>0.581
<sup>a</sup>
</td>
<td>0.566</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3 mFU</td>
<td>52.50±13.31</td>
<td>53.25±5.87</td>
<td>49.79±12.59</td>
<td>0.280
<sup>a</sup>
</td>
<td>0.758</td>
</tr>
<tr>
<td>Digit span backward T-scores</td>
<td></td>
<td>Baseline</td>
<td>49.00±11.59</td>
<td>43.43±6.13§</td>
<td>47.14±9.35</td>
<td>0.677
<sup>a</sup>
</td>
<td>0.517</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3 mFU</td>
<td>49.13±12.68</td>
<td>41.88±19.78</td>
<td>45.15±7.16</td>
<td>0.866
<sup>b</sup>
</td>
<td>0.649</td>
</tr>
<tr>
<td>Verbal fluency (letters) T-scores</td>
<td></td>
<td>Baseline</td>
<td>54.58±8.75</td>
<td>47.67±9.06§</td>
<td>49.93±10.25</td>
<td>1.050
<sup>a</sup>
</td>
<td>0.364</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3 mFU</td>
<td>47.87±6.88*</td>
<td>46.63±9.95</td>
<td>50.02±10.95</td>
<td>0.333
<sup>a</sup>
</td>
<td>0.720</td>
</tr>
<tr>
<td>Brief test of attention raw scores</td>
<td></td>
<td>Baseline</td>
<td>11.88±4.12</td>
<td>9.86±3.53§</td>
<td>10.14±4.69</td>
<td>0.535
<sup>a</sup>
</td>
<td>0.592</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3 mFU</td>
<td>9.00±4.14</td>
<td>11.25±3.06</td>
<td>10.07±4.83</td>
<td>0.560
<sup>a</sup>
</td>
<td>0.578</td>
</tr>
<tr>
<td>Quality of life</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>PDQ-39</td>
<td></td>
<td>Baseline</td>
<td>47.09±19.46</td>
<td>34.71±16.05</td>
<td>33.58±13.55</td>
<td>2.001
<sup>a</sup>
</td>
<td>0.155</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3 mFU</td>
<td>43.17±14.01†,‡,§</td>
<td>20.44±9.28†*</td>
<td>21.56±12.06‡**</td>
<td>9.143
<sup>a</sup>
</td>
<td>0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values represent means±SD. p Values by
<sup>a</sup>
ANOVA (F) or
<sup>b</sup>
Kruskall–Wallis H-test (χ
<bold>
<sup>2</sup>
</bold>
).</p>
</fn>
<fn>
<p>*Represent significant changes for paired samples t test for UPDRS-III (baseline med off vs 3 mFU stim on/med off), LEDD, PDQ-39 and verbal fluency data within a group, *<0.05, **<0.01, ***<0.001.</p>
</fn>
<fn>
<p>†Bonferroni posthoc test: significant difference between group-neg and group-mix.</p>
</fn>
<fn>
<p>‡Bonferroni posthoc test: significant difference between group-neg and group-pos.</p>
</fn>
<fn>
<p>§Missing data for one patient.</p>
</fn>
<fn>
<p>N, number of patients; group-neg, subjective outcome negative; group-mix, subjective outcome mixed; group-pos, subjective outcome positive; med off, medication off; stim on, stimulation on; 3 mFU, 3 months follow-up; UPDRS, Unified Parkinson's Disease Rating Scale-III; LEDD, l-dopa equivalent daily dose; PDQ-39, Parkinson's Disease Questionnaire-39.</p>
</fn>
<fn>
<p>Test score range: UPDRS-III, 0–108, higher scores equal more impairment; digit span forwards, 0–100, higher scores equal better performance; digit span backwards, 0–100, higher scores equal better performance; verbal fluency (letters), 0–100, higher scores equal better performance; brief test of attention, 0–20, higher scores equal better performance; PDQ-39, 0–100, higher scores equal more impaired quality of life.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="JNNP2012303670TB3" position="float">
<label>Table 3</label>
<caption>
<p>Group comparisons of mood scales at baseline and 3 months after surgery</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"></col>
<col align="char" char="."></col>
<col align="char" char="."></col>
<col align="char" char="."></col>
<col align="char" char="."></col>
<col align="char" char="."></col>
</colgroup>
<thead valign="bottom">
<tr>
<th></th>
<th align="left">Group-neg (n=8)</th>
<th align="left">Group-mix (n=8)</th>
<th align="left">Group-pos (n=14)</th>
<th align="left">F</th>
<th align="left">p Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Apathy evaluation scale</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td> Baseline</td>
<td>45.25±11.52†,‡</td>
<td>29.88±8.59†</td>
<td>31.64±7.85‡</td>
<td>7.251</td>
<td>0.003</td>
</tr>
<tr>
<td> 3 mFU</td>
<td>44.50±7.15†,‡</td>
<td>27.00±6.63†</td>
<td>33.31±6.85‡</td>
<td>13.465</td>
<td><0.001</td>
</tr>
<tr>
<td>Beck depression inventory-2</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td> Baseline</td>
<td>18.25±8.70†</td>
<td>6.63±6.28†</td>
<td>11.43±4.89</td>
<td>6.626</td>
<td>0.005</td>
</tr>
<tr>
<td> 3 mFU</td>
<td>18.38±5.83†,‡</td>
<td>5.88±9.19†</td>
<td>7.36±6.86‡*</td>
<td>7.541</td>
<td>0.003</td>
</tr>
<tr>
<td>Self-report manic inventory</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td> Baseline</td>
<td>7.25±6.50</td>
<td>2.75±3.85</td>
<td>7.07±6.06</td>
<td>1.742</td>
<td>0.194</td>
</tr>
<tr>
<td> 3 mFU</td>
<td>11.14±6.62§</td>
<td>3.75±3.28</td>
<td>10.14±7.36</td>
<td>3.328</td>
<td>0.052</td>
</tr>
<tr>
<td>State trait anxiety inventory state</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td> Baseline</td>
<td>49.63±14.44</td>
<td>34.63±9.40</td>
<td>40.14±8.99</td>
<td>4.009</td>
<td>0.030</td>
</tr>
<tr>
<td> 3 mFU</td>
<td>47.00±7.64§</td>
<td>34.13±11.84</td>
<td>35.14±8.87</td>
<td>4.413</td>
<td>0.022</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values represent means±SD.</p>
</fn>
<fn>
<p>*Represents significant changes for paired samples t test for BDI-2 results within group-pos, *<0.01.</p>
</fn>
<fn>
<p>†Bonferroni posthoc test: significant difference between group-neg and group-mix.</p>
</fn>
<fn>
<p>‡Bonferroni posthoc test: significant difference between group-neg and group-pos.</p>
</fn>
<fn>
<p>§Missing data for one patient.</p>
</fn>
<fn>
<p>Group-neg, subjective outcome negative; group-mix, subjective outcome mixed; group-pos, subjective outcome positive; 3 mFU, 3 months follow-up.</p>
</fn>
<fn>
<p>Test score range: apathy evaluation scale, 18–72, higher values equal more apathy; Beck depression inventory-2, 0–63, higher values equal more depression; self-report manic inventory, 0–48, higher values equal more mania; state trait anxiety inventory, 20–80, higher values equal more state anxiety.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="s3c1">
<title>Neurological data</title>
<p>Corrected levels of significance were determined for baseline (p=0.017; 0.05 divided by 3) and 3 mFU (p=0.025; 0.05 divided by 2). No significant group differences were found for UPDRS-III on-score and off-score, and LEDD at baseline and 3 mFU. Within the groups, paired samples t tests revealed significant improvement of UPDRS-III scores (baseline med off vs 3 mFU stim on/med off) and reduced LEDD for each group.</p>
</sec>
<sec id="s3c2">
<title>Neuropsychological measures</title>
<p>Applying corrected levels of significance (baseline and 3 mFU: p=0.0125) no group differences were found in any cognitive test results. Within the groups, verbal fluency significantly worsened in group-neg. All other within-group changes were not significant.</p>
</sec>
<sec id="s3c3">
<title>Quality of life</title>
<p>No significant group difference was found for the PDQ-base, although group-neg had the worst QoL. At 3 mFU, PDQ-scores were significantly higher in group-neg compared with group-mix and group-pos. Within-group changes revealed that QoL only significantly improved in group-mix and group-pos.</p>
</sec>
<sec id="s3c4">
<title>Mood scales</title>
<p>One-way ANOVAs (see
<xref ref-type="table" rid="JNNP2012303670TB3">table 3</xref>
) showed significant group differences on the AES and BDI-2 at baseline and 3 mFU applying a corrected level of significance of 0.0125 (0.05 divided by 4 for both time points). Apathy scores were significantly worse in group-neg compared with group-mix and group-pos, verified by posthoc Bonferroni test, at baseline and 3 mFU. Depression scores were significantly higher in group-neg compared with group-mix at baseline, and significantly higher compared with group-mix and group-pos at 3 mFU. State anxiety of the STAI tended to be higher in group-neg compared with group-mix at baseline, and higher in group-neg compared with group-mix and group-pos at 3 mFU. No significant result was found for the SRMI at baseline and 3 mFU. Paired samples t tests showed that only in group-pos, depression significantly improved at 3 mFU.</p>
</sec>
</sec>
<sec id="s3d">
<title>Predictors of subjective negative outcome</title>
<p>Baseline group comparisons revealed AES-scores and BDI-2-scores as showing significant differences between group-neg (N=8) and the other groups (N=22). Therefore, AES and BDI-2 were included in the binary logistic regression analysis. Both tests remained as significant predictors and accounted for 65.8% of the variance (Nagelkerkes R
<sup>2</sup>
). This model correctly classified 27 of 30 patients (90%), applying a criterion value of 0.5. The sensitivity to find patients with negative subjective outcome (true positive cases) was 87.5% (7 out of 8), while the specificity (true negative cases) was 90.9% (20 out of 22). The AUC was 0.86 for the AES (p=0.003, 95% CI 0.71 to 1.00) and 0.78 for the BDI-2 (p=0.022, 95% CI 0.55 to 1.00). The ROC curves are shown in
<xref ref-type="fig" rid="JNNP2012303670F4">figure 4</xref>
. The optimal cut-off score (best trade-off between sensitivity and specificity) on the AES was 36/37 (sensitivity=0.75, specificity=0.73), and a score of 16/17 on the BDI-2 (sensitivity=0.75, specificity=0.86). To reduce the false positive rate (1-specificity), a higher cut-off score can be determined. For the AES, a score of 42/43 (sensitivity=0.63, specificity=0.91) and for the BDI-2 a score of 17/18 (sensitivity=0.63, specificity=0.91), reduces the probability of false positives.</p>
<fig id="JNNP2012303670F4">
<label>Figure 4</label>
<caption>
<p>Receiver operating characteristic curves and cut-off scores for apathy (AES) and depression (BDI-2).</p>
</caption>
<graphic xlink:href="jnnp-84-1273-F4.jpg"></graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>This is the first study reporting data on PD patients’ expectations of STN-DBS, and on how patients subjectively perceive their outcome at 3 months after surgery. Clearly, all patients expected motor improvement from DBS, and the majority expected improvement in QoL. At 3 mFU, 14 patients reported a subjective positive outcome, 8 patients a mixed outcome, and 8 patients a subjective negative outcome. The latter had significantly higher apathy and depression scores at baseline and 3 mFU, even though motor scores significantly improved. Also, binary logistic regression analysis identified AES and BDI-2 baseline scores as significant predictors of a negative subjective outcome. Cut-off scores of 36/37 for the AES and of 16/17 for the BDI-2 are being suggested.</p>
<p>Considering our results, it has to be questionable whether group-neg patients should be considered as candidates for STN-DBS, even though they fulfilled the formal criteria for DBS surgery, according to leading expert's opinions.
<xref ref-type="bibr" rid="R19">19</xref>
<xref ref-type="bibr" rid="R33">33</xref>
Group-neg had the best preoperative motor on-state compared with the other groups. Therefore, it might have been better to continue treatment exclusively with antiparkinsonian medication. However, despite their subjective negative outcome, group-neg experienced significant motor improvements by STN-DBS as measured with the UPDRS-III. Also, their LEDD decreased significantly from baseline to 3 mFU. Therefore, these patients cannot be considered as ‘motor non-responders’. Still, group-neg did not improve in QoL and even worsened in verbal fluency.</p>
<p>It may seem unexpected, that group-neg presented with best preoperative motor functioning and l-dopa response, but had the highest apathy and depression scores at the same time. Past studies have shown that apathy and overall motor impairment were not associated, implying an involvement of non-motor frontal-subcortical loops.
<xref ref-type="bibr" rid="R34">34</xref>
<xref ref-type="bibr" rid="R35">35</xref>
Similar results have been reported for depression and motor impairment,
<xref ref-type="bibr" rid="R36">36</xref>
although this relationship often depends on how depression and its severity was assessed, and what other psychiatric comorbidities existed.
<xref ref-type="bibr" rid="R37">37</xref>
<xref ref-type="bibr" rid="R38">38</xref>
Further research is needed to clarify the association between severity of apathy, depression and overall motor symptoms.</p>
<p>As a baseline expectation, group-neg patients significantly more often named ‘improvement of mental state’, which can usually not be directly improved by DBS, and which might therefore be considered as unrealistic. Too high and unrealistic expectations can lead to disappointment with DBS outcome, even though patients might have marked motor improvement.
<xref ref-type="bibr" rid="R39">39</xref>
<xref ref-type="bibr" rid="R40">40</xref>
Moreover, a patient with more complaints than beneficial changes after DBS is a high burden for the family, the society paying for the procedure, as well as for the involved medical team.</p>
<p>There is an ongoing debate on psychiatric symptoms as possible exclusion criteria for STN-DBS.
<xref ref-type="bibr" rid="R33">33</xref>
Large trials on the efficiency and side effects of STN-DBS usually do not define specific cut-off scores for exclusion but, instead, exclude patients with major or severe psychiatric disorders.
<xref ref-type="bibr" rid="R1">1</xref>
<xref ref-type="bibr" rid="R2">2</xref>
Also, severe medication-refractory depression is a recommended exclusion criterion for DBS, generally based on DSM-IV diagnosis.
<xref ref-type="bibr" rid="R41">41</xref>
In our study, patients with subjective negative outcome showed significantly more apathy and depression compared with the other groups at baseline and 3 mFU, although preoperative severe psychiatric diseases were not found by an experienced psychiatrist. An explanation for the high affective test scores might be l-dopa-induced mood swings or neurovegetative elevation of BDI-2-scores. Nevertheless, apathy and depression are frequent non-motor symptoms in PD.
<xref ref-type="bibr" rid="R3">3</xref>
The relationship between these mood impairments is still unclear. It has been suggested that apathy and depression are discrete components in PD,
<xref ref-type="bibr" rid="R42">42</xref>
while others emphasise an overlap between these two.
<xref ref-type="bibr" rid="R43">43</xref>
Regarding the use of the AES in PD, cut-off scores of 37/38, and for the BDI-2, cut-off scores of 14/15, have been shown to separate patients with apathy/depression from those without.
<xref ref-type="bibr" rid="R44">44</xref>
<xref ref-type="bibr" rid="R45">45</xref>
With respect to exclusion from DBS therapy, no specific cut-off scores have been defined for the use of these scales. We found cut-off scores of 36/37 on the AES, and of 16/17 on the BDI-2, to be the most sensitive and specific cut-offs, to predict possible subjective negative outcomes in our patient group. This finding suggests that patients should be screened carefully before surgery, and even milder or subclinical psychiatric difficulties should raise our attention with respect to subjective patient outcome and approval to have STN-DBS surgery. Furthermore, apathy and depression should be treated prior to surgery to improve subjective patient outcomes. Also, counselling or psychotherapy accompanying the DBS-procedure might be helpful to stabilise patient's affective state and make sure that expectations can be fulfilled.
<xref ref-type="bibr" rid="R46">46</xref>
</p>
<p>Apathy and depression also decrease QoL in PD.
<xref ref-type="bibr" rid="R17">17</xref>
<xref ref-type="bibr" rid="R18">18</xref>
We assume that the preoperative affective state (ie, high apathy and depression scores) of patients with postoperative negative subjective outcome contributes to the unimproved QoL at 3 mFU. We speculate that preoperative apathy and depression prevents improvement of QoL after surgery. Regarding neuropsychological results, a worsening in verbal fluency, especially in the more depressed group-neg, is not surprising, since this is a frequent cognitive change after STN-DBS.
<xref ref-type="bibr" rid="R33">33</xref>
</p>
<p>Our study has several limitations. The small sample size may limit statistical results and power. However, the very time-consuming assessment, transcription and evaluation of semistructured interviews usually reduce the number of patients. The use of semistructured interviews makes a comparison between patients more difficult since each person answers questions according to their own perception. Therefore, the objectivity of our interview results is reduced. Moreover, neutral interview responses were not considered in the analysis, which could lead to loss of information. Another limitation is the early follow-up examination at 3 months after surgery. Until now, we were not able to make an assumption regarding the subjective outcome of groups beyond this time point. Further research is needed to examine patients’ subjective perception in the long run.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>PD patients who undergo STN-DBS have specific hopes and wishes regarding a successful outcome of surgery that does not simply depend on motor improvement. Like others,
<xref ref-type="bibr" rid="R40">40</xref>
<xref ref-type="bibr" rid="R41">41</xref>
we recommend to discuss expectations with the patient before surgery and highlight probable realistic benefits. It seems that a more careful examination of preoperative depression and apathy, as well as a more limited approval for surgery in the case of moderate psychiatric disorders, increases the patient's subjective positive outcome. Preoperative apathy and depression scores might be helpful tools to identify ‘risk candidates’ for STN-DBS, providing the opportunity of an accompanying psychosocial support and counselling. Future studies which analyse subjective patient outcomes longitudinally are crucial to get a better understanding of the long-term impact of STN-DBS on a patient's life.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<label>Contributors</label>
<p>FM and CJL made substantial contributions to: conception and design, acquisition of data, analysis and interpretation of data; drafting the article and revising it critically for important intellectual content; final approval of the version to be published.</p>
</fn>
<fn>
<p>NH made substantial contributions to: acquisition of data and analysis; revising it critically for important intellectual content; final approval of the version to be published.</p>
</fn>
<fn>
<p>CE, MZ and EM made substantial contributions to: analysis and interpretation of data; revising it critically for important intellectual content; final approval of the version to be published.</p>
</fn>
<fn>
<p>EK, JK and CW made substantial contributions to: conception and design and interpretation of data; revising it critically for important intellectual content; final approval of the version to be published.</p>
</fn>
<fn>
<p>MM made substantial contributions to: acquisition of data and interpretation of data; revising it critically for important intellectual content; final approval of the version to be published.</p>
</fn>
<fn>
<p>LT made substantial contributions to: conception and design, acquisition of data and analysis; revising it critically for important intellectual content; final approval of the version to be published.</p>
</fn>
<fn>
<label>Funding</label>
<p>This study was funded by the German Ministry of Education and Research (BMBF), and by the Canadian Institute of Health Research. This study was part of the international and interdisciplinary project ‘Ethical, Legal, and Social Aspects of Deep Brain Stimulation (ELSA-DBS)’. (
<ext-link xlink:href="http://geschichte-ethik.uk-koeln.de/forschungsstelle-ethik/forschung-1/elsa-dbs" ext-link-type="uri">http://geschichte-ethik.uk-koeln.de/forschungsstelle-ethik/forschung-1/elsa-dbs</ext-link>
). FM and CL were employed through a grant of the German Parkinson Foundation (Deutsche Parkinson Vereinigung) in 2012 and 2013.</p>
</fn>
<fn>
<label>Competing interests</label>
<p>F Maier reports no disclosures. C Lewis reports no disclosures. N Horstkoetter reports no disclosures. C Eggers has received speaker's honoraria from Medtronic Inc. E Kalbe has received honoraria from Novartis and is consultant for Novartis. M Maarouf has received speaker's honoraria from Medtronic Inc. J Kuhn has received honoraria from AstraZeneca, Lilly, Lundbeck and Otsuka Pharma for lecturing at conferences and financial support to travel. J Kuhn received financial support for IIT-DBS studies (not the present investigation) from Medtronic GmbH (Meerbusch, Germany). M Zurowski reports no disclosures. E Moro has received honoraria from Medtronic for consulting services and lecturing. She has also received research support from St Jude Medical, CurePSP, CIHR and educational grant support from Medtronic in the past 12 months. C Woopen reports no disclosures. L Timmermann is consultant for Medtronic Inc, Boston Scientific, Bayer Healthcare, UCB Schwarz Pharma, received honoraria in symposia sponsored by TEVA Pharma, Lundbeck Pharma, Bracco, Gianni PR, Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boehringer Ingelheim, GlaxoSmithKline, Eumecom, Orion Pharma, Medtronic, Boston Scientific, Cephalon, Abott, GE Medical. The institution of Professor Timmermann, not Prof Timmermann himself, received funding by the German Research Foundation (DFG) via the Clinical Research Group 219, the German Ministry of Education and Research (BMBF), Manfred und Ursula Müller Stiftung, Klüh Stiftung, Hoffnungsbaum e. V., NBIA DISORDERS SOCIETY USA, the medical faculty of the University of Cologne via the ‘Köln Fortune program’, Medtronic Inc, and the German Parkinson Foundation (Deutsche Parkinson Vereinigung).</p>
</fn>
<fn>
<label>Ethics approval</label>
<p>Ethics commission of the University Hospital of Cologne.</p>
</fn>
<fn>
<label>Provenance and peer review</label>
<p>Not commissioned; externally peer reviewed.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="R1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deuschl</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schade-Brittinger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krack</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>A randomized trial of deep-brain stimulation for Parkinson's disease</article-title>
.
<source>N Engl J Med</source>
<year>2006</year>
;
<volume>355</volume>
:
<fpage>896</fpage>
<lpage>908</lpage>
.</citation>
</ref>
<ref id="R2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Reiff</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study</article-title>
.
<source>Lancet Neurol</source>
<year>2008</year>
;
<volume>7</volume>
:
<fpage>605</fpage>
<lpage>14</lpage>
.</citation>
</ref>
<ref id="R3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weintraub</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Burn</surname>
<given-names>DJ</given-names>
</name>
</person-group>
.
<article-title>Parkinson's disease: the quintessential neuropsychiatric disorder</article-title>
.
<source>Mov Disord</source>
<year>2011</year>
;
<volume>26</volume>
:
<fpage>1022</fpage>
<lpage>31</lpage>
.</citation>
</ref>
<ref id="R4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkinson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Peto</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score</article-title>
.
<source>Age Ageing</source>
<year>1997</year>
;
<volume>26</volume>
:
<fpage>353</fpage>
<lpage>7</lpage>
.</citation>
</ref>
<ref id="R5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diamond</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jankovic</surname>
<given-names>J</given-names>
</name>
</person-group>
.
<article-title>The effect of deep brain stimulation on quality of life in movement disorders</article-title>
.
<source>J Neurol Neurosurg Psychiatry</source>
<year>2005</year>
;
<volume>76</volume>
:
<fpage>1188</fpage>
<lpage>93</lpage>
.</citation>
</ref>
<ref id="R6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schupbach</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gargiulo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Welter</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Neurosurgery in Parkinson disease: a distressed mind in a repaired body?</article-title>
<source>Neurology</source>
<year>2006</year>
;
<volume>66</volume>
:
<fpage>1811</fpage>
<lpage>16</lpage>
.</citation>
</ref>
<ref id="R7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drapier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raoul</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Drapier</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease</article-title>
.
<source>J Neurol</source>
<year>2005</year>
;
<volume>252</volume>
:
<fpage>583</fpage>
<lpage>8</lpage>
.</citation>
</ref>
<ref id="R8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montel</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Bungener</surname>
<given-names>C</given-names>
</name>
</person-group>
.
<article-title>Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus</article-title>
.
<source>Surg Neurol</source>
<year>2009</year>
;
<volume>72</volume>
:
<fpage>105</fpage>
<lpage>10</lpage>
;
<comment>discussion 10–1</comment>
.</citation>
</ref>
<ref id="R9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nisenzon</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Bowers</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment?</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2011</year>
;
<volume>17</volume>
:
<fpage>89</fpage>
<lpage>94</lpage>
.</citation>
</ref>
<ref id="R10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mathieu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Racine</surname>
<given-names>E</given-names>
</name>
</person-group>
.
<article-title>Preparing the ethical future of deep brain stimulation</article-title>
.
<source>Surg Neurol</source>
<year>2009</year>
;
<volume>72</volume>
:
<fpage>577</fpage>
<lpage>86</lpage>
;
<comment>discussion 86</comment>
.</citation>
</ref>
<ref id="R11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clausen</surname>
<given-names>J</given-names>
</name>
</person-group>
.
<article-title>Ethical brain stimulation—neuroethics of deep brain stimulation in research and clinical practice</article-title>
.
<source>Eur J Neurosci</source>
<year>2010</year>
;
<volume>32</volume>
:
<fpage>1152</fpage>
<lpage>62</lpage>
.</citation>
</ref>
<ref id="R12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudmeyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Volkmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wojtecki</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Deep brain stimulation—expectations and doubts: a nationwide questionnaire study of patients with Parkinson's disease and their family members</article-title>
.
<source>Nervenarzt</source>
<year>2012</year>
;
<volume>83</volume>
:
<fpage>481</fpage>
<lpage>6</lpage>
.</citation>
</ref>
<ref id="R13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniels</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krack</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Volkmann</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?</article-title>
<source>Mov Disord</source>
<year>2011</year>
;
<volume>26</volume>
:
<fpage>2516</fpage>
<lpage>21</lpage>
.</citation>
</ref>
<ref id="R14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smeding</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Speelman</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Huizenga</surname>
<given-names>HM</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease</article-title>
.
<source>J Neurol Neurosurg Psychiatry</source>
<year>2011</year>
;
<volume>82</volume>
:
<fpage>754</fpage>
<lpage>60</lpage>
.</citation>
</ref>
<ref id="R15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soulas</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sultan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gurruchaga</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Depression and coping as predictors of change after deep brain stimulation in Parkinson's disease</article-title>
.
<source>World Neurosurg</source>
<year>2011</year>
;
<volume>75</volume>
:
<fpage>525</fpage>
<lpage>32</lpage>
.</citation>
</ref>
<ref id="R16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krack</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease</article-title>
.
<source>J Neurol Sci</source>
<year>2011</year>
;
<volume>310</volume>
:
<fpage>261</fpage>
<lpage>6</lpage>
.</citation>
</ref>
<ref id="R17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schrag</surname>
<given-names>A</given-names>
</name>
</person-group>
.
<article-title>Quality of life and depression in Parkinson's disease</article-title>
.
<source>J Neurol Sci</source>
<year>2006</year>
;
<volume>248</volume>
:
<fpage>151</fpage>
<lpage>7</lpage>
.</citation>
</ref>
<ref id="R18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benito-Leon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cubo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Coronell</surname>
<given-names>C</given-names>
</name>
</person-group>
.
<article-title>Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study</article-title>
.
<source>Mov Disord</source>
<year>2012</year>
;
<volume>27</volume>
:
<fpage>211</fpage>
<lpage>18</lpage>
.</citation>
</ref>
<ref id="R19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilker</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Benecke</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Deuschl</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Deep brain stimulation for Parkinson's disease. Consensus recommendations of the German Deep Brain Stimulation Association</article-title>
.
<source>Nervenarzt</source>
<year>2009</year>
;
<volume>80</volume>
:
<fpage>646</fpage>
<lpage>55</lpage>
.</citation>
</ref>
<ref id="R20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalbe</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia</article-title>
.
<source>Int J Geriatr Psychiatry</source>
<year>2004</year>
;
<volume>19</volume>
:
<fpage>136</fpage>
<lpage>43</lpage>
.</citation>
</ref>
<ref id="R21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folstein</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Folstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>McHugh</surname>
<given-names>PR</given-names>
</name>
</person-group>
.
<article-title>‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician</article-title>
.
<source>J Psychiatr Res</source>
<year>1975</year>
;
<volume>12</volume>
:
<fpage>189</fpage>
<lpage>98</lpage>
.</citation>
</ref>
<ref id="R22">
<label>22</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Mayring</surname>
<given-names>P</given-names>
</name>
</person-group>
.
<article-title>Qualitative content analysis</article-title>
.
<comment>Forum: Qualitative Social Research</comment>
,
<year>2000</year>
;
<comment>1(2)</comment>
.</citation>
</ref>
<ref id="R23">
<label>23</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Mayring</surname>
<given-names>P</given-names>
</name>
</person-group>
.
<source>Qualitative Inhaltsanalyse. Grundlagen und Techniken</source>
.
<publisher-loc>Weinheim</publisher-loc>
:
<publisher-name>Beltz</publisher-name>
,
<year>2008</year>
.</citation>
</ref>
<ref id="R24">
<label>24</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Fahn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Elton</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Committee</surname>
<given-names>UD</given-names>
</name>
</person-group>
.
<article-title>Unified Parkinson's disease rating scale</article-title>
. In:
<person-group person-group-type="editor">
<name>
<surname>Fahn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marsden</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Calne</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>M</given-names>
</name>
</person-group>
, eds.
<source>Recent developments in Parkinson's disease</source>
.
<publisher-loc>Floral Park, NY</publisher-loc>
:
<publisher-name>MacMillan Healthcare Information</publisher-name>
,
<year>1987</year>
:
<fpage>153</fpage>
<lpage>63</lpage>
.</citation>
</ref>
<ref id="R25">
<label>25</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name>
<surname>Diener</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Putzki</surname>
<given-names>N</given-names>
</name>
</person-group>
, eds.
<source>Leitlinien für Diagnostik und Therapie in der Neurologie</source>
.
<edition>4th edn</edition>
.
<publisher-loc>Stuttgart</publisher-loc>
:
<publisher-name>Georg Thieme Verlag</publisher-name>
,
<year>2008</year>
.</citation>
</ref>
<ref id="R26">
<label>26</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Härting</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Markowitsch</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Neufeld</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
.
<source>WMS-R—Wechsler Gedächtnistest—revidierte Fassung</source>
.
<publisher-loc>Bern</publisher-loc>
:
<publisher-name>Huber</publisher-name>
,
<year>2000</year>
.</citation>
</ref>
<ref id="R27">
<label>27</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Aschenbrenner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tucha</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>KW</given-names>
</name>
</person-group>
.
<source>Regensburger Wortflüssigkeits-Test (RWT)</source>
.
<publisher-loc>Göttingen</publisher-loc>
:
<publisher-name>Hogrefe</publisher-name>
,
<year>2000</year>
.</citation>
</ref>
<ref id="R28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schretlen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bobholz</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>J</given-names>
</name>
</person-group>
.
<article-title>Development and psychometric properties of the brief test of attention</article-title>
.
<source>Clin Neuropsychologist</source>
<year>1996</year>
;
<volume>10</volume>
:
<fpage>80</fpage>
<lpage>9</lpage>
.</citation>
</ref>
<ref id="R29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marin</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Biedrzycki</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Firinciogullari</surname>
<given-names>S</given-names>
</name>
</person-group>
.
<article-title>Reliability and validity of the Apathy Evaluation Scale</article-title>
.
<source>Psychiatry Res</source>
<year>1991</year>
;
<volume>38</volume>
:
<fpage>143</fpage>
<lpage>62</lpage>
.</citation>
</ref>
<ref id="R30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beck</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Steer</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients</article-title>
.
<source>J Pers Assess</source>
<year>1996</year>
;
<volume>67</volume>
:
<fpage>588</fpage>
<lpage>97</lpage>
.</citation>
</ref>
<ref id="R31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shugar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schertzer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Toner</surname>
<given-names>BB</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Development, use, and factor analysis of a self-report inventory for mania</article-title>
.
<source>Compr Psychiatry</source>
<year>1992</year>
;
<volume>33</volume>
:
<fpage>325</fpage>
<lpage>31</lpage>
.</citation>
</ref>
<ref id="R32">
<label>32</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Spielberger</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Gorssuch</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Lushene</surname>
<given-names>PR</given-names>
</name>
<etal></etal>
</person-group>
.
<source>Manual for the State-Trait Anxiety Inventory</source>
.
<publisher-name>Consulting Psychologists Press, Inc.</publisher-name>
,
<year>1983</year>
.</citation>
</ref>
<ref id="R33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bronstein</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tagliati</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alterman</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues</article-title>
.
<source>Arch Neurol</source>
<year>2011</year>
;
<volume>68</volume>
:
<fpage>165</fpage>
.</citation>
</ref>
<ref id="R34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pluck</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RG</given-names>
</name>
</person-group>
.
<article-title>Apathy in Parkinson's disease</article-title>
.
<source>J Neurol Neurosurg Psychiatry</source>
<year>2002</year>
;
<volume>73</volume>
:
<fpage>636</fpage>
<lpage>42</lpage>
.</citation>
</ref>
<ref id="R35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dujardin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sockeel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Devos</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Characteristics of apathy in Parkinson's disease</article-title>
.
<source>Mov Disord</source>
<year>2007</year>
;
<volume>22</volume>
:
<fpage>778</fpage>
<lpage>84</lpage>
.</citation>
</ref>
<ref id="R36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starkstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Preziosi</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Bolduc</surname>
<given-names>PL</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Depression in Parkinson's disease</article-title>
.
<source>J Nerv Ment Dis</source>
<year>1990</year>
;
<volume>178</volume>
:
<fpage>27</fpage>
<lpage>31</lpage>
.</citation>
</ref>
<ref id="R37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starkstein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dragovic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jorge</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis</article-title>
.
<source>Mov Disord</source>
<year>2011</year>
;
<volume>26</volume>
:
<fpage>2239</fpage>
<lpage>45</lpage>
.</citation>
</ref>
<ref id="R38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starkstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Brockman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hayhow</surname>
<given-names>BD</given-names>
</name>
</person-group>
.
<article-title>Psychiatric syndromes in Parkinson's disease</article-title>
.
<source>Current opinion in psychiatry</source>
<year>2012</year>
;
<volume>25</volume>
:
<fpage>468</fpage>
<lpage>72</lpage>
.</citation>
</ref>
<ref id="R39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Haq</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Pearls in patient selection for deep brain stimulation</article-title>
.
<source>Neurologist</source>
<year>2007</year>
;
<volume>13</volume>
:
<fpage>253</fpage>
<lpage>60</lpage>
.</citation>
</ref>
<ref id="R40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Foote</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders</article-title>
.
<source>Parkinsonism Relat Disord</source>
<year>2008</year>
;
<volume>14</volume>
:
<fpage>532</fpage>
<lpage>8</lpage>
.</citation>
</ref>
<ref id="R41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Saint-Cyr</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lozano</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery</article-title>
.
<source>J Neurosurg</source>
<year>2005</year>
;
<volume>103</volume>
:
<fpage>246</fpage>
<lpage>51</lpage>
.</citation>
</ref>
<ref id="R42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirsch-Darrow</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marsiske</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okun</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Apathy and depression: separate factors in Parkinson's disease</article-title>
.
<source>J Int Neuropsychol Soc</source>
<year>2011</year>
;
<volume>17</volume>
:
<fpage>1058</fpage>
<lpage>66</lpage>
.</citation>
</ref>
<ref id="R43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starkstein</surname>
<given-names>SE</given-names>
</name>
</person-group>
.
<article-title>Apathy in Parkinson's disease: diagnostic and etiological dilemmas</article-title>
.
<source>Mov Disord</source>
<year>2012</year>
;
<volume>27</volume>
:
<fpage>174</fpage>
<lpage>8</lpage>
.</citation>
</ref>
<ref id="R44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leentjens</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Dujardin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations</article-title>
.
<source>Mov Disord</source>
<year>2008</year>
;
<volume>23</volume>
:
<fpage>2004</fpage>
<lpage>14</lpage>
.</citation>
</ref>
<ref id="R45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leentjens</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Marinus</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
.
<article-title>Reliability and validity of the Beck depression inventory in patients with Parkinson's disease</article-title>
.
<source>Mov Disord</source>
<year>2006</year>
;
<volume>21</volume>
:
<fpage>668</fpage>
<lpage>72</lpage>
.</citation>
</ref>
<ref id="R46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woopen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Timmermann</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>J</given-names>
</name>
</person-group>
.
<article-title>An ethical framework for outcome assessment in psychiatric DBS</article-title>
.
<source>AJOB Neuroscience</source>
<year>2012</year>
;
<volume>3</volume>
:
<fpage>50</fpage>
<lpage>5</lpage>
.</citation>
</ref>
</ref-list>
</back>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<partName>Research paper</partName>
<title>Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<partName>Research paper</partName>
<title>Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach</title>
</titleInfo>
<name type="personal">
<namePart type="given">Franziska</namePart>
<namePart type="family">Maier</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Catharine J</namePart>
<namePart type="family">Lewis</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nina</namePart>
<namePart type="family">Horstkoetter</namePart>
<affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Carsten</namePart>
<namePart type="family">Eggers</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Elke</namePart>
<namePart type="family">Kalbe</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<affiliation>Institute for Gerontology, University of Vechta, Vechta, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Mohammad</namePart>
<namePart type="family">Maarouf</namePart>
<affiliation>Department of Stereotaxy and Functional Neurosurgery, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Jens</namePart>
<namePart type="family">Kuhn</namePart>
<affiliation>Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Mateusz</namePart>
<namePart type="family">Zurowski</namePart>
<affiliation>Department of Psychiatry, Department of Medicine, University of Toronto, University Health Network, Toronto, Ontario, Canada</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Elena</namePart>
<namePart type="family">Moro</namePart>
<affiliation>Movement Disorders Unit, Department of Psychiatry and Neurology, University Hospital Center (CHU) of Grenoble, Grenoble, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Christiane</namePart>
<namePart type="family">Woopen</namePart>
<affiliation>Research Unit Ethics, Institute for the History of Medicine and Medical Ethics, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Lars</namePart>
<namePart type="family">Timmermann</namePart>
<affiliation>Department of Neurology, University of Cologne, Cologne, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article">research-article</genre>
<subject>
<genre>heading</genre>
<topic>Movement disorders</topic>
</subject>
<subject>
<genre>heading</genre>
<topic>JNNP Patients' choice</topic>
</subject>
<originInfo>
<publisher>BMJ Publishing Group Ltd</publisher>
<dateIssued encoding="w3cdtf">2013-11</dateIssued>
<dateCreated encoding="w3cdtf">2013-05-28</dateCreated>
<copyrightDate encoding="w3cdtf">2013</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract>Objective To study patients’ expectations of subthalamic deep brain stimulation (STN-DBS) and their subjective perceived outcome, by using qualitative and quantitative methods in Parkinson's disease (PD). Methods PD patients were prospectively examined before and 3 months after surgery. Semistructured interviews regarding preoperative expectations and postsurgical subjective perceived outcome were conducted. These were analysed using content analysis. For statistical analyses, patients were classified according to their subjective perceived outcome, resulting in three different subjective outcome groups (negative, mixed, positive outcome). The groups were used for multiple comparisons between and within each group regarding motor impairment, quality of life (QoL), neuropsychiatric status and cognitive functioning, using standard instruments. A logistic regression analysis was conducted to find predictors of subjective negative outcome. Receiver operating characteristic curves were used to analyse cut-off scores for predictive tests. Results Of the 30 PD patients participating, 8 had a subjective negative outcome, 8 a mixed and 14 a positive outcome. All groups significantly improved in motor functioning. Patients with subjective negative outcome were characterised by preoperative unrealistic expectations, no postsurgical improvement in QoL, and significantly higher presurgical and postsurgical apathy and depression scores. Higher preoperative apathy and depression scores were significant predictors of negative subjective outcome. Cut-off scores for apathy and depression were identified. Conclusions The mixed-method approach proved useful in examining a patient's subjective perception of STN-DBS outcome. Our results show that significant motor improvement does not necessarily lead to a positive subjective outcome. Moreover, PD patients should be screened carefully before surgery regarding apathy and depression. (DRKS-ID: DRKS00003221).</abstract>
<note type="footnotes">FM and CJL contributed equally.</note>
<subject>
<genre>Keywords</genre>
<topic>PARKINSON'S DISEASE</topic>
<topic>NEUROPSYCHIATRY</topic>
<topic>NEUROPSYCHOLOGY</topic>
<topic>QUALITY OF LIFE</topic>
<topic>STEREOTAXIC SURGERY</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Journal of Neurology, Neurosurgery & Psychiatry</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>J Neurol Neurosurg Psychiatry</title>
</titleInfo>
<identifier type="ISSN">0022-3050</identifier>
<identifier type="eISSN">1468-330X</identifier>
<identifier type="JournalID">jnnp</identifier>
<identifier type="JournalID-hwp">jnnp</identifier>
<identifier type="JournalID-nlm-ta">J Neurol Neurosurg Psychiatry</identifier>
<part>
<date>2013</date>
<detail type="volume">
<caption>vol.</caption>
<number>84</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>11</number>
</detail>
<extent unit="pages">
<start>1273</start>
</extent>
</part>
</relatedItem>
<identifier type="istex">436610088435E9614BE05D633E7A803476F69355</identifier>
<identifier type="DOI">10.1136/jnnp-2012-303670</identifier>
<identifier type="href">jnnp-84-1273.pdf</identifier>
<identifier type="ArticleID">jnnp-2012-303670</identifier>
<identifier type="PMID">23715910</identifier>
<accessCondition type="use and reproduction" contentType="Copyright">Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</accessCondition>
<recordInfo>
<recordContentSource>BMJ</recordContentSource>
</recordInfo>
</mods>
</metadata>
<annexes>
<json:item>
<original>true</original>
<mimetype>image/jpeg</mimetype>
<extension>jpeg</extension>
<uri>https://api.istex.fr/document/436610088435E9614BE05D633E7A803476F69355/annexes/jpeg</uri>
</json:item>
</annexes>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000399 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000399 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:436610088435E9614BE05D633E7A803476F69355
   |texte=   Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach
}}

Wicri

This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024